The Role of TIMP-2 in RenoVō®: A Key Component in Amniotic Tissue Allografts for Equine Use

Sep 1, 2025 | Clinical Study

Veterinarians seeking consistent, natural options to support equine tissue health are increasingly exploring amniotic tissue-based products. RenoVō® is a ready-to-use, acellular amniotic tissue allograft developed specifically for equine use. One of the naturally...

RenoVō^® Case Study Hoof Injury: Foal

Jul 14, 2025 | Clinical Study

Case presentation: On March 9, 2021, a three-day-old foal presented with a hoof injury. The mother accidently stepped on the foal’s hoof at two days old, resulting in a severely detached hoof. The detached hoof wall was trimmed off and 3.0 cc of RenoVo® was...

Cryopreserved Liquid Amnion Product vs. Powder (Lyophilized) Amnion Product

Apr 10, 2025 | News

Amniotic tissue contains naturally occurring elements such as growth factors, cytokines, extracellular matrix proteins, and exosomes. These components are intrinsic to the native structure of the amniotic membrane and fluid and may be beneficial in supporting tissue...

Comparing Equine Therapy Options: PRP vs. RenoVō^®

Dec 23, 2024 | News

The key difference between PRP (Platelet-Rich Plasma) and RenoVō® lies in consistency, composition, and practical application. While PRP relies on platelets collected and processed on-site, RenoVō® is a ready-to-use, acellular equine amniotic tissue allograft prepared...

Alternative to PRP for Equines: Why Consider RenoVō^®

Dec 22, 2024 | News

Why RenoVō®? Alternative to PRP Platelet-Rich Plasma (PRP) has been widely used in equine regenerative care, but it isn’t without its challenges. PRP preparations can vary significantly depending on blood quality, processing techniques, and the presence of white blood...